tiprankstipranks
Sienna Biopharmaceuticals Inc. (SNNAQ)
:SNNAQ
US Market

Sienna Biopharmaceuticals (SNNAQ) Income Statement

Compare
71 Followers

Sienna Biopharmaceuticals Income Statement

Last quarter (Q3 2019), Sienna Biopharmaceuticals's total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Sienna Biopharmaceuticals's net income was $-3.97M. See Sienna Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -157.00K
Operating Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 76.50M
Depreciation and Amortization
$ 228.49K$ 236.56K$ 206.30K$ 171.86K$ 157.00K
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00$ -76.34M
Operating Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -76.50M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 3.03M
Pretax Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -73.47M
Net Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -73.31M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -3.59
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -3.59
Weighted Average Shares Outstanding
0.00 0.00 0.00 0.00 20.45M
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 0.00 0.00 20.45M
Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis